Incannex Healthcare Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · Australia

Last price 2.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.37M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is developing IHL-675A, an oral fixed dos...